Extension of PLI scheme, more incentives to improve ease of doing business and Prioritizing Research and Development are ...

At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

UK contract development and manufacturing organization Upperton Pharma Solutions has completed the build of its new sterile ...

Contract Pharmaceutical Manufacturing Market is expected to reach USD 403.45 Bn by 2031, exhibiting a compound annual growth rate of 9.7% from 2024 to 2031. BURLINGAME, CA, UNITED STATES ...

Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of ...

Contract Development and Manufacturing (CDMO) player Piramal Pharma posted a 12.5 per cent growth in revenues in the third ...

The global pharmaceutical manufacturing market size was valued at USD 589.06 billion in 2024 and is projected to reach from ...

Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a ...